We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use a randomised controlled trial to evaluate your digital health product.
How to use a micro-randomised trial to evaluate your digital health product.
How to use a quasi-experimental study to evaluate your digital health product.
How to use a factorial randomised controlled trial to evaluate your digital health product.
From 1 October 2024, more materials facilities will need to sample and report their waste. Sampling and reporting will be more detailed and more frequent under the amended regulations.
Helping public health practitioners conducting evaluations – using outcome evaluations to find out if an intervention works.
Distinguishes randomised controlled trials from other types of study within research papers to help NICE staff narrow down the number of papers they need to read and review for evidence synthesis.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).